{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:42:53Z","timestamp":1793090573013,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","award":["0010091"],"award-info":[{"award-number":["0010091"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.euf.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T01:23:17Z","timestamp":1638926597000},"page":"1238-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Berghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Junius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Liefhooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"No\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"De Meerleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Villeirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"De Maeseneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rammant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Verghote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Elhaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"De Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Decaestecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.11.004_b0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neo-adjuvant chemotherapy for muscle invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.euf.2021.11.004_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2021.11.004_b0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.eururo.2015.04.021","article-title":"Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium","volume":"68","author":"Raza","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.11.004_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijrobp.2012.03.061","article-title":"Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy","volume":"85","author":"Baumann","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2021.11.004_b0025","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.11.004_b0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis on adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.11.004_b0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eururo.2014.01.008","article-title":"Thoughts on a systematic review and metaanalysis of adjuvant chemotherapy in muscle-invasive bladder cancer","volume":"66","author":"Sternberg","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.11.004_b0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2021.11.004_b0045","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab vs placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2021.11.004_b0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.28544","article-title":"Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710","volume":"120","author":"Christodouleas","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2021.11.004_b0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0360-3016(92)90005-3","article-title":"Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease-free survival through improving local control","volume":"22","author":"Zaghloul","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2021.11.004_b0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<743::AID-CNCR21>3.0.CO;2-#","article-title":"Distant metastasis from bilharzial bladder cancer","volume":"77","author":"Zaghloul","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2021.11.004_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0360-3016(92)91060-Z","article-title":"Combined pre- and postoperative adjuvant radiotherapy for bladder cancer\u2014a 10 year experience","volume":"24","author":"Reisinger","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2021.11.004_b0070","doi-asserted-by":"crossref","first-page":"e174591","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy A randomized phase 2 trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.euf.2021.11.004_b0075","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12885-017-3302-9","article-title":"Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial","volume":"17","author":"Fonteyne","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2021.11.004_b0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy Oncology group (RTOG) and the European Organization for Research and Treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2021.11.004_b0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semi Radiat Oncol"},{"key":"10.1016\/j.euf.2021.11.004_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043266","article-title":"Short-term morbidity and mortality following radical cystectomy: a systematic review","volume":"11","author":"Maibom","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.euf.2021.11.004_b0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clgc.2017.05.007","article-title":"Tolerance of orthotopic ileal neobladders to radiotherapy: a multi-institutional retrospective study","volume":"6","author":"Ballas","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2021.11.004_b0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1470-2045(14)71160-X","article-title":"Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial","volume":"16","author":"Sternberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2021.11.004_b0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.euo.2018.08.009","article-title":"Modeling 1-year relapse-free survival after neoadjuvant chemotherapy and radical cystectomy in patients with clinical T2\u20134N0M0 urothelial bladder carcinoma: endpoints for phase 2 trials","volume":"2","author":"Bandini","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2021.11.004_b0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.eururo.2019.06.032","article-title":"Incremental utility of adjuvant chemotherapy in muscle-invasive bladder cancer: quantifying the relapse risk associated with therapeutic effect","volume":"76","author":"Pedorzili","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.11.004_b0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/jcm10040651","article-title":"Impact of adjuvant chemotherapy on survival of patients with advanced residual disease at radical cystectomy following neo-adjuvant chemotherapy: systematic review and meta-analysis","volume":"10","author":"Krajewski","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.euf.2021.11.004_b0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ctrv.2018.07.011","article-title":"Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: a systematic review and framework for adjuvant radiotherapy","volume":"70","author":"Sargos","year":"2018","journal-title":"Cancer treat Rev"},{"key":"10.1016\/j.euf.2021.11.004_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40336-020-00397-7","article-title":"PET-CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?","volume":"9","author":"Fonteyne","year":"2020","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.euf.2021.11.004_b0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clgc.2011.05.004","article-title":"Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent","volume":"9","author":"Ploeg","year":"2011","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2021.11.004_b0135","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejso.2016.02.011","article-title":"Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: a 20 year single center experience","volume":"42","author":"Moschini","year":"2016","journal-title":"EJSO"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:56:03Z","timestamp":1762498563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2405456921003047"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.11.004","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}